Involvement of purinergic signaling on nitric oxide production by neutrophils stimulated with Trichomonas vaginalis

Purinergic Signalling

Volumn 8, Issue 1, 2012, Pages 1-9

  Frasson, Amanda Piccoli ^a   De Carli, Geraldo Attilio ^b   Bonan, Carla Denise ^b   Tasca, Tiana ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adenosine; Ectonucleotidases; Neutrophils; Nitric oxide; Purinergic signaling; Trichomonas vaginalis

Indexed keywords

2 [4 (2 CARBOXYETHYL) PHENETHYLAMINO] ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CAFFEINE; ECTO 5' NUCLEOTIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INOSINE; N (G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NUCLEOSIDE TRANSPORTER; PURINERGIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; SIGNAL TRANSDUCTION; TRICHOMONAS VAGINALIS; TROPHOZOITE;

EID: 84857685537     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-011-9254-7     Document Type: Article

References (50)

1. World Health Organization (2001) Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. World Health Organization, Geneva.
2. Cotch MF, Pastorek JG, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG (1997) The vaginal infections and prematurity study group. Sex Transm Dis 24: 353-360. doi:10.1097/00007435-199707000-00008.
3. Goldstein F, Goldman MB, Cramer DW (1993) Relation of tubal infertility to a story of sexually transmitted diseases. Am J Epidemiol 137: 577-584.
4. Viikki M, Pukkala E, Nieminen P, Hakama M (2000) Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol (Madr) 39: 71-75. doi:10.1080/028418600431003.
5. Cherpes T, Wiesenfeld H, Melan M, Kant JA, Consentino LA, Meyn LA, Hillier SL (2006) The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis 33: 747-752. doi: 10. 1097/01.olq.0000218869.52753.c7.
6. Johnston VJ, Mabey DC (2008) Global epidemiology and control of Trichomonas vaginalis. Curr Opin Infect Dis 21: 56-64. doi:10.1097/QCO.0b013e3282f3d999.
7. van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, van De Wijgert J, Miro F, Mugerwa R, Chipato T, Morrison CS (2008) Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 197: 548-554. doi:10.1086/526496.
8. Petrin D, Delgaty K, Bhatt R, Garber G (1998) Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 11: 300-317.
9. Lehker MW, Alderete JF (2000) Biology of trichomonosis. Curr Opin Infect Dis 13: 37-45.
10. Fichorova RN (2009) Impact of T. vaginalis infection on innate immune responses and reproductive outcome. J Reprod Immunol 83: 185-189. doi:10.1016/j.jri.2009.08.007.
11. Escario A, Gómez Barrio A, Simons Diez B, Escario JA (2010) Immunohistochemical study of the vaginal inflammatory response in experimental trichomoniasis. Acta Trop 114: 22-30. doi:10.1016/j.actatropica.2009.12.002.
12. Ryu JS, Kang JH, Jung SY, Shin MH, Kim JM, Park H, Min DY (2004) Production of interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis. Infect Immun 72: 1326-1332. doi:10.1128/IAI.72.3.1326-1332.2004.
13. Shaio MF, Lin PR, Liu JY, Yang KD (1995) Generation of interleukin-8 from human monocytes in response to Trichomonas vaginalis stimulation. Infect Immun 63: 3864-3870.
14. Park GC, Ryu JS, Min DY (1997) The role of nitric oxide as an effector of macrophage-mediated cytotoxicity against Trichomonas vaginalis. Korean J Parasitol 35: 189-195. doi:10.3347/kjp.1997.35.3.189.
15. Shaio MF, Lin PR, Lee CS, Hou SC, Tang P, Yanga KD (1992) Novel neutrophil-activating factor released by Trichomonas vaginalis. Infect Immun 60: 4475-4482.
16. Shaio MF, Lin PR (1995) Leukotriene B4 levels in the vaginal discharges from cases of trichomoniasis. Ann Trop Med Parasitol 89: 85-88.
17. Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6: 1191-1197. doi:10.1038/ni1276.
18. Yegutkin GG (2008) Nucleotide-and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783: 673-694. doi:10.1016/j.bbamcr.2008.01.024.
19. Salmi M, Jalkanen S (2005) Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 5: 760-771. doi:10.1038/nri1705.
20. Bours MJL, Swennen ELR, Di Virgilio F, Cronstein BN, Dagnelie PC (2006) Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Therapeut 112: 358-404. doi:10.1016/j.pharmthera.2005.04.013.
21. Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87: 659-797. doi:10.1152/physrev.00043.2006.
22. Zimmermann H (2001) Ectonucleotidases: some recent developments and a note on nomenclature. Drug Develop Res 52: 44-56. doi:10.1002/ddr.1097.
23. Robson SC, Sévigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2: 409-430. doi:10.1007/s11302-006-9003-5.
24. Matos JAA, Borges FP, Tasca T, Bogo MR, De Carli GA, Fauth MG, Dias RD, Bonan CD (2001) Characterization of an ATP diphosphohydrolase (Apyrase, EC 3. 6. 1. 5) activity in Trichomonas vaginalis. Int J Parasitol 31: 770-775. doi:10.1016/S0020-7519(01)00191-6.
25. Tasca T, Bonan CD, De Carli GA, Battastini AMO, Sarkis JJF (2003) Characterization of an ecto-5′-nucleotidase (EC 3. 1. 3. 5) activity in intact cells of Trichomonas vaginalis. Exp Parasitol 105: 167-173. doi:10.1016/j.exppara.2003.12.001.
26. Weizenmann M, Frasson AP, de Barros MP, Vieira Pde B, Rosemberg DB, De Carli GA, Bogo MR, Bonan CD, Tasca T (2011) Kinetic characterization and gene expression of adenosine deaminase in intact trophozoites of Trichomonas vaginalis. FEMS Microbiol Lett 319: 115-124. doi:10.1111/j.1574-6968.2011.02283.x.
27. Diamond LS (1957) The establishment of various Trichomonas of animals and man in axenic cultures. J Parasitol 43: 488-490.
28. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 218-254. doi:10.1016/0003-2697(76)90527-3.
29. Chan KM, Delfert D, Junger KD (1986) A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem 157: 375-380. doi:10.1016/0003-2697(86)90640-8.
30. Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97: 77-89.
31. Di Virgilio F (2007) Purinergic signalling in the immune system. A brief update. Purinergic Signal 3: 1-3. doi:10.1007/s11302-006-9048-5.
32. Junger GW (2008) Purinergic regulation of neutrophil chemotaxis. Cell Mol Life Sci 65: 2528-2540. doi:10.1007/s00018-008-8095-1.
33. Chen Y, Yao Y, Sumi Y, Li A, To UK, Elkhal A, Inoue Y, Woehrle T, Zhang Q, Hauser C, Junger WG (2010) Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci Signal 125: ra45. doi:10.1126/scisignal.2000549.
34. Armstrong R (2001) The physiological role and pharmacological potential of nitric oxide in neutrophil activation. Int Immunopharmacol 1: 1501-1512. doi:10.1016/S1567-5769(01)00094-7.
35. Wink DA, Mitchell JB (1998) Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 25: 434-456. doi:10.1016/S0891-5849(98)00092-6.
36. Zagryazhskaya NA, Lindner SC, Grishina ZV, Galkina SI, Steinhilber D, Sud'ina GF (2010) Nitric oxide mediates distinct effects of various LPS chemotypes on phagocytosis and leukotriene synthesis in human neutrophils. Int J Biochem Cell Biol 42: 921-931. doi:10.1016/j.biocel.2010.01.025.
37. Han IH, Goo SY, Park SJ, Hwang SJ, Kim YS, Yang MS, Ahn MH, Ryu JS (2009) Proinflammatory cytokine and nitric oxide production by human macrophages stimulated with Trichomonas vaginalis. Korean J Parasitol 47: 205-212. doi:10.3347/kjp.2009.47.3.205.
38. Malla N, Yadav M, Gupta I (2007) Kinetics of serum and local cytokine profile in experimental intravaginal trichomoniasis induced with Trichomonas vaginalis isolates from symptomatic and asymptomatic women. Parasite Immunol 29: 101-105. doi:10.1111/j.1365-3024.2006.00914.x.
39. Coleman J (2001) Nitric oxide in immunity and inflammation. Int Immunopharmacol 1: 1397-1406. doi:10.1016/S1567-5769(01)00086-8.
40. Pulte ED, Broekman MJ, Olson KE, Drosopoulos JHF, Kizer JR, Islam N, Marcus AJ (2007) CD39/NTPDase-1 activity and expression in normal leukocytes. Thromb Res 121: 309-317. doi:10.1016/j.thromres.2007.04.008.
41. Lévesque SA, Lavoie EG, Lecka J, Bigonnesse F, Sévigny J (2007) Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br J Pharmacol 152: 141-150. doi:10.1038/sj.bjp.0707361.
42. Sansom FM, Robson SC, Hartland EL (2008) Possible effects of microbial ecto-nucleoside triphosphate diphosphohydrolases on host-pathogen interactions. Microbiol Mol Biol Rev 72: 765-781. doi:10.1128/MMBR.00013-08.
43. Alderete JF, Millsap KW, Lehker MW, Benchimol M (2001) Enzymes on microbial pathogens and Trichomonas vaginalis: molecular mimicry and functional diversity. Cell Microbiol 3: 359-370. doi:10.1046/j.1462-5822.2001.00126.x.
44. Tasca T, Bonan CD, De Carli GA, Sarkis JJ, Alderete JF (2005) Heterogeneity in extracellular nucleotide hydrolysis among clinical isolates of Trichomonas vaginalis. Parasitology 131: 71-78. doi:10.1017/S0031182005007377.
45. Haskó G, Cronstein BN (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25: 33-39. doi:10.1016/j.it.2003.11.003.
46. Haskó G, Sitkovsky MV, Szabó C (2004) Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 25: 152-157. doi:10.1016/j.tips.2004.01.006.
47. Heyworth PG, Gutteridge WE, Ginger CD (1982) Purine metabolism in Trichomonas vaginalis. FEBS Lett 141: 106-110. doi:10.1016/0014-5793(82)80026-4.
48. Heyworth PG, Gutteridge WE, Ginger CD (1984) Pyrimidine metabolism in Trichomonas vaginalis. FEBS Lett 176: 55-60. doi:10.1016/0014-5793(84)80910-2.
49. Fortin A, Harbour D, Fernandes M, Borgeat P, Bourgoin S (2006) Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide. J Leukoc Biol 79: 574-585. doi:10.1189/jlb.0505249.
50. 2A receptors promotes fMLP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes. J Leukoc Biol 71: 367-377.